UK close to securing 60 million COVID-19 vaccine doses from Sanofi/GSK

Britain is close to agreeing a £500 million ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, The Sunday Times reported.
The newspaper said that Britain was considering taking an option to buy the vaccine should it work in human trials, which are due to begin in September.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use